Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Search

Case Studies

Knowledge and technology transfer in practice

Browse through examples of patents, translation projects, start-ups and product developments. This will give you the most precise impression of the work we do with our partners in science and industry

Everyone has back pain at some point or other. Between 20 and 30% of Europeans have chronic back pain, and in 5% of these cases the cause is...

Around 400,000 people in Germany suffer a heart attack each year. In a fifth of those affected, this leads to a complex process of restructuring in...

In 2017 Ascenion also supported the transfer of EU-financed research projects, for example as a consortium partner on projects in the European...

The vision of introducing genes into human cells to heal life-threatening diseases is more than 50 years old. Today, the first gene therapies are...

The art of a successful breast cancer operation lies in being able to remove as much cancerous tissue as possible and avoid the formation of...

Pseudomonas aeruginosa is a much-feared hospital germ. It can cause dangerous infections, is extremely resilient, and has acquired multiple resistance...

2016 saw the market launch of a new test from Roche Diagnostics: Elecsys GDF-15. Based on research by Prof. Kai C. Wollert at the Hannover Medical...

Funding of EUR 3.5 million was secured in June 2016 by Prof. Reinhard Zeidler and his team at the Helmholtz Zentrum München. The support comes from...

With Ascenion‘s help, the MDC established a unique translational centre in 2016 - the ‚Max-Delbrück Center Cell Engineering Lab‘ (MD-CEL). Its goal is...

In September 2016 the Max Delbrück Center for Molecular Medicine (MDC) and the WILEX subsidiary Heidelberg Pharma signed an option agreement with the...

Chronic Obstructive Pulmonary Disease is characterized by the persistent narrowing of the airways, often leading to difficulties in breathing and...

EUR 9 million Series A financing was secured by HepaRegeniX at the end of 2016 – sufficient to further advance its innovative approach to the...

Meningococci, the main pathogens of bacterial meningitis, still cause epidemics in certain regions in the world, for example in Africa and India....

July 2015 saw the start of a Phase II clinical study in South Africa – a tuberculosis hot spot. For the first time, infants exposed to HIV received...

In the past year, Ascenion intensively accompanied the spin-off amcure as part of the Spinnovator programme. This start-up from the Karlsruhe...